National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
米国
引用
ジャーナル: Proc Natl Acad Sci U S A / 年: 2021 タイトル: Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins. 著者: Joël S Bloch / Somnath Mukherjee / Julia Kowal / Ekaterina V Filippova / Martina Niederer / Els Pardon / Jan Steyaert / Anthony A Kossiakoff / Kaspar P Locher / 要旨: With conformation-specific nanobodies being used for a wide range of structural, biochemical, and cell biological applications, there is a demand for antigen-binding fragments (Fabs) that ...With conformation-specific nanobodies being used for a wide range of structural, biochemical, and cell biological applications, there is a demand for antigen-binding fragments (Fabs) that specifically and tightly bind these nanobodies without disturbing the nanobody-target protein interaction. Here, we describe the development of a synthetic Fab (termed NabFab) that binds the scaffold of an alpaca-derived nanobody with picomolar affinity. We demonstrate that upon complementary-determining region grafting onto this parent nanobody scaffold, nanobodies recognizing diverse target proteins and derived from llama or camel can cross-react with NabFab without loss of affinity. Using NabFab as a fiducial and size enhancer (50 kDa), we determined the high-resolution cryogenic electron microscopy (cryo-EM) structures of nanobody-bound VcNorM and ScaDMT, both small membrane proteins of ∼50 kDa. Using an additional anti-Fab nanobody further facilitated reliable initial three-dimensional structure determination from small cryo-EM test datasets. Given that NabFab is of synthetic origin, is humanized, and can be conveniently expressed in in large amounts, it may be useful not only for structural biology but also for biomedical applications.
#256 - 2021年4月 SARSコロナウイルス2型のスパイクと抗体 (SARS-CoV-2 Spike and Antibodies) 類似性 (1)
-
集合体
登録構造単位
A: Fragment Antigen-Binding Light Chain B: Fragment Antigen-Binding Heavy Chain C: Fragment Antigen-Binding Light Chain D: Fragment Antigen-Binding Heavy Chain E: Fragment Antigen-Binding Light Chain F: Fragment Antigen-Binding Heavy Chain G: Fragment Antigen-Binding Light Chain H: Fragment Antigen-Binding Heavy Chain I: Fragment Antigen-Binding Light Chain J: Fragment Antigen-Binding Heavy Chain K: Fragment Antigen-Binding Light Chain L: Fragment Antigen-Binding Heavy Chain M: Fragment Antigen-Binding Light Chain N: Fragment Antigen-Binding Heavy Chain O: Fragment Antigen-Binding Light Chain P: Fragment Antigen-Binding Heavy Chain Q: Fragment Antigen-Binding Light Chain R: Fragment Antigen-Binding Heavy Chain a: Nanobody c: Nanobody e: Nanobody g: Nanobody i: Nanobody k: Nanobody m: Nanobody o: Nanobody q: Nanobody ヘテロ分子
C: Fragment Antigen-Binding Light Chain D: Fragment Antigen-Binding Heavy Chain E: Fragment Antigen-Binding Light Chain F: Fragment Antigen-Binding Heavy Chain c: Nanobody e: Nanobody ヘテロ分子
G: Fragment Antigen-Binding Light Chain H: Fragment Antigen-Binding Heavy Chain I: Fragment Antigen-Binding Light Chain J: Fragment Antigen-Binding Heavy Chain g: Nanobody i: Nanobody ヘテロ分子
K: Fragment Antigen-Binding Light Chain L: Fragment Antigen-Binding Heavy Chain M: Fragment Antigen-Binding Light Chain N: Fragment Antigen-Binding Heavy Chain k: Nanobody m: Nanobody ヘテロ分子
O: Fragment Antigen-Binding Light Chain P: Fragment Antigen-Binding Heavy Chain Q: Fragment Antigen-Binding Light Chain R: Fragment Antigen-Binding Heavy Chain o: Nanobody q: Nanobody ヘテロ分子